Notre Dame Hosts Thomas H. Quinn Speaker Series Featuring Dr. Ron DePinho on Reversing Aging
Ronald DePinho will share fresh insights into the science of aging, how aging contributes to diseases such as cancer and Alzheimer’s, and the potential of emerging research to extend the human healthspan.
- Published
Related News & Stories
In the Classroom
New minors expand access to business education
More business minors are now available to all Notre Dame students—and new minors expand the educational offerings at Mendoza
Analytics & Technology
Reimagining Dementia Care
At the 2026 Shamrock Series, scholars from the Human-centered Analytics Lab demonstrated how in-person facilitators combined with social robots using generative AI can deliver personalized reminiscence therapy for memory care patients.

Mendoza
Meet Notre Dame’s newest business faculty members
Mendoza College of Business welcomes a new cohort of scholars whose research shapes how the College teaches and thinks about today's business challenges.
The event is open to all Notre Dame students, faculty, staff and campus visitors. No registration or tickets required; seating is limited.
DePinho will share fresh insights into the science of aging, how aging contributes to diseases such as cancer and Alzheimer’s, and the potential of emerging research to extend the human healthspan.
He has contributed foundational research tying telomere dysfunction and aging to cancer and degenerative disease, and led initiatives such as the Cancer Moon Shots Program to accelerate the translation of scientific breakthroughs into clinical outcomes.
Before his leadership at MD Anderson (2011–2017), he held key roles at Harvard Medical School; the Belfer Institute for Applied Cancer Science, where he was founding director; and at the Dana-Farber Cancer Institute.